Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT.

Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT.

Item
http://www.wikidata.org/entity/Q35850723
Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responsesA CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors.Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice.Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma.The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitorsMaximizing CD8+ T cell responses elicited by peptide vaccines containing CpG oligodeoxynucleotides.Toll-like receptors in tumor immunotherapy.A comparison and critical analysis of preclinical anticancer vaccination strategies.Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.Initial therapy in multiple myeloma: investigating the new treatment paradigm.Unravelling the complexity of cancer-immune system interplay.Lymphoma immunotherapy: vaccines, adoptive cell transfer and immunotransplant.Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions.Analogue peptides for the immunotherapy of human acute myeloid leukemia.
P2860

Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT.

Item
http://www.wikidata.org/entity/Q35850723
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Vaccination regimens incorpora ...... eripheral expansion after BMT.
@ast
Vaccination regimens incorpora ...... eripheral expansion after BMT.
@en
type
label
Vaccination regimens incorpora ...... eripheral expansion after BMT.
@ast
Vaccination regimens incorpora ...... eripheral expansion after BMT.
@en
prefLabel
Vaccination regimens incorpora ...... eripheral expansion after BMT.
@ast
Vaccination regimens incorpora ...... eripheral expansion after BMT.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Vaccination regimens incorpora ...... eripheral expansion after BMT.
@en
P2093
P2860
P304
P31
P356
10.1182/BLOOD-2006-11-057935
P407
P433
P478
P577
P5875
P698
P932